Mkts

RenovoRx, Inc.

NASDAQ: RNXT
$1.18+0.00 (+0.00%)
As of Nov 10, 4:00 PM ET

Key statistics

Day range
1.111.22
52-week range
0.702.59
Today
Open1.18
Previous close1.18
Volume—
Valuation
Market cap56.94M
P/E ratio—
EPS (TTM)-0.31
Income & risk
Dividend / yield—
Beta1.22
Avg volume665.8K
Discussion

RNXT News

Stories mentioning RNXT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue563.00238.00266.00422.00197.00
Cost of Goods Sold84.0028.0053.00152.0094.00
Gross Profit479.00210.00213.00270.00103.0043.000.000.00
Operating Expenses
Research & Development1,2281,5161,6851,4261,6421,5761,6501,542
Sales General & Admin2,7202,2161,7281,5221,5711,0991,1781,492
Total Operating Expenses3,9483,7323,4132,9483,2132,6752,8283,034
Operating Income (Loss)(3,469)(3,522)(3,200)(2,678)(3,110)(2,632)(2,828)(3,034)
Interest Income
Interest Expense
Other Expense
Pretax Income
Tax Provision0.000.00
Net Income (Loss)(3,521)(2,941)(2,912)(2,895)(2,420)(2,878)(2,471)(2,389)
Earnings Per Share (Basic)(0.09)(0.08)(0.08)(0.08)(0.08)(0.13)(0.10)(0.10)
Earnings Per Share (Diluted)(0.09)(0.08)(0.08)(0.08)(0.08)(0.13)(0.10)(0.10)
Weighted Average Shares Outstanding (Basic)38,03235,33336,64636,57731,39622,27124,94124,049
Weighted Average Shares Outstanding (Diluted)38,03235,33336,64636,57731,39622,27124,94124,049

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RNXT

RenovoRx, Inc. (NASDAQ: RNXT) is a stock listed on the Nasdaq Stock Market under the ticker symbol RNXT. It last traded at $1.18 (Nov 10, 2026, 4:00 PM ET), unchanged on the day. That gives RenovoRx a market capitalisation of $56.9M.

Over the past 52 weeks RNXT has traded between $0.7000 and $2.59.

Revenue for the quarter ended Mar 31, 2026 was $563.0K; a net loss of $3.5M. Revenue was up 186% from $197.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$563.0K-$3.5M-625.4%
Dec 31, 2025$238.0K-$2.9M-1235.7%
Sep 30, 2025$266.0K-$2.9M-1094.7%
Jun 30, 2025$422.0K-$2.9M-686.0%

From RenovoRx’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…